Literature DB >> 34694168

The Use of Expert Elicitation among Computational Modeling Studies in Health Research: A Systematic Review.

Christopher J Cadham1, Marie Knoll2, Luz María Sánchez-Romero2, K Michael Cummings3, Clifford E Douglas1,4, Alex Liber2, David Mendez1, Rafael Meza5, Ritesh Mistry6, Aylin Sertkaya7, Nargiz Travis1,2, David T Levy2.   

Abstract

BACKGROUND: Expert elicitation (EE) has been used across disciplines to estimate input parameters for computational modeling research when information is sparse or conflictual.
OBJECTIVES: We conducted a systematic review to compare EE methods used to generate model input parameters in health research. DATA SOURCES: PubMed and Web of Science. STUDY ELIGIBILITY: Modeling studies that reported the use of EE as the source for model input probabilities were included if they were published in English before June 2021 and reported health outcomes. DATA ABSTRACTION AND SYNTHESIS: Studies were classified as "formal" EE methods if they explicitly reported details of their elicitation process. Those that stated use of expert opinion but provided limited information were classified as "indeterminate" methods. In both groups, we abstracted citation details, study design, modeling methodology, a description of elicited parameters, and elicitation methods. Comparisons were made between elicitation methods. STUDY APPRAISAL: Studies that conducted a formal EE were appraised on the reporting quality of the EE. Quality appraisal was not conducted for studies of indeterminate methods.
RESULTS: The search identified 1520 articles, of which 152 were included. Of the included studies, 40 were classified as formal EE and 112 as indeterminate methods. Most studies were cost-effectiveness analyses (77.6%). Forty-seven indeterminate method studies provided no information on methods for generating estimates. Among formal EEs, the average reporting quality score was 9 out of 16. LIMITATIONS: Elicitations on nonhealth topics and those reported in the gray literature were not included.
CONCLUSIONS: We found poor reporting of EE methods used in modeling studies, making it difficult to discern meaningful differences in approaches. Improved quality standards for EEs would improve the validity and replicability of computational models. HIGHLIGHTS: We find extensive use of expert elicitation for the development of model input parameters, but most studies do not provide adequate details of their elicitation methods.Lack of reporting hinders greater discussion of the merits and challenges of using expert elicitation for model input parameter development.There is a need to establish expert elicitation best practices and reporting guidelines.

Entities:  

Keywords:  computational modeling; expert elicitation; expert judgment; expert opinion; systematic review

Mesh:

Year:  2021        PMID: 34694168      PMCID: PMC9035479          DOI: 10.1177/0272989X211053794

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.749


  176 in total

1.  Cost-effectiveness of expanded newborn screening in Texas.

Authors:  Simrandeep K Tiwana; Karen L Rascati; Haesuk Park
Journal:  Value Health       Date:  2012-06-07       Impact factor: 5.725

2.  Economic evaluation of fulvestrant 500 mg versus generic nonsteroidal aromatase inhibitors in patients with advanced breast cancer in the United Kingdom.

Authors:  Romita Das; Shannon Cope; Mario Ouwens; Pauline Turner; Matthew Howlett
Journal:  Clin Ther       Date:  2013-02-28       Impact factor: 3.393

3.  Use (and abuse) of expert elicitation in support of decision making for public policy.

Authors:  M Granger Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

4.  Cost-effectiveness of a targeted disinfection program in household kitchens to prevent foodborne illnesses in the United States, Canada, and the United Kingdom.

Authors:  Steven B Duff; Elizabeth A Scott; Michael S Mafilios; Ewen C Todd; Leonard R Krilov; Alasdair M Geddes; Stacey J Ackerman
Journal:  J Food Prot       Date:  2003-11       Impact factor: 2.077

5.  Carmustine implants for the treatment of newly diagnosed high-grade gliomas: a cost-utility analysis.

Authors:  Gabriel Rogers; Ruth Garside; Stuart Mealing; Martin Pitt; Rob Anderson; Matthew Dyer; Ken Stein; Margaret Somerville
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

6.  Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey.

Authors:  Yoel Lubell; Sarah G Staedke; Brian M Greenwood; Moses R Kamya; Malcolm Molyneux; Paul N Newton; Hugh Reyburn; Robert W Snow; Umberto D'Alessandro; Mike English; Nick Day; Peter Kremsner; Arjen Dondorp; Wilfred Mbacham; Grant Dorsey; Seth Owusu-Agyei; Kathryn Maitland; Sanjeev Krishna; Charles Newton; Geoffrey Pasvol; Terrie Taylor; Lorenz von Seidlein; Nicholas J White; Fred Binka; Anne Mills; Christopher J M Whitty
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

7.  Modelling the cost-effectiveness of public awareness campaigns for the early detection of non-small-cell lung cancer.

Authors:  S Hinde; C McKenna; S Whyte; M D Peake; M E J Callister; T Rogers; M Sculpher
Journal:  Br J Cancer       Date:  2015-05-26       Impact factor: 7.640

8.  A Cost-Effectiveness Tool to Guide the Prioritization of Interventions for Rheumatic Fever and Rheumatic Heart Disease Control in African Nations.

Authors:  David Watkins; Solomon J Lubinga; Bongani Mayosi; Joseph B Babigumira
Journal:  PLoS Negl Trop Dis       Date:  2016-08-11

9.  Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany.

Authors:  Daniel Wirth; Ramesh Dass; Robert Hettle
Journal:  BMC Health Serv Res       Date:  2017-03-08       Impact factor: 2.655

Review 10.  Use of Expert Judgement Across NICE Guidance-Making Programmes: A Review of Current Processes and Suitability of Existing Tools to Support the Use of Expert Elicitation.

Authors:  Alison Peel; Michelle Jenks; Moni Choudhury; Rosemary Lovett; Juan Carlos Rejon-Parrilla; Andrew Sims; Joyce Craig
Journal:  Appl Health Econ Health Policy       Date:  2018-12       Impact factor: 2.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.